KLSE (MYR): MBRIGHT (2097)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.165
Today's Change
0.00 (0.00%)
Day's Change
0.165 - 0.17
Trading Volume
391,900
Market Cap
413 Million
NOSH
2,505 Million
Latest Quarter
31-Mar-2024 [#3]
Announcement Date
29-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
29-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
-88.59% | -48.84%
Revenue | NP to SH
63,231.000 | 9,275.000
RPS | P/RPS
2.52 Cent | 6.54
EPS | P/E | EY
0.37 Cent | 44.57 | 2.24%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.11 | 1.55
QoQ | YoY
-3.07% | -3.27%
NP Margin | ROE
14.44% | 3.47%
F.Y. | Ann. Date
31-Mar-2024 | 29-May-2024
Latest Audited Result
30-Jun-2023
Announcement Date
31-Oct-2023
Next Audited Result
30-Jun-2024
Est. Ann. Date
31-Oct-2024
Est. Ann. Due Date
27-Dec-2024
Revenue | NP to SH
34,067.000 | 8,670.000
RPS | P/RPS
1.36 Cent | 12.13
EPS | P/E | EY
0.35 Cent | 47.68 | 2.10%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.09 | 1.77
YoY
93.48%
NP Margin | ROE
25.49% | 3.71%
F.Y. | Ann. Date
30-Jun-2023 | 29-Aug-2023
Revenue | NP to SH
72,480.000 | 3,777.333
RPS | P/RPS
2.89 Cent | 5.70
EPS | P/E | EY
0.15 Cent | 109.44 | 0.91%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-38.52% | 2.13%
NP Margin | ROE
5.94% | 1.41%
F.Y. | Ann. Date
31-Mar-2024 | 29-May-2024
Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
last month Meta Bright was forming a joint venture with Bumiputera firm Doople Tech Sdn Bhd for renewable energy (RE) projects. Next Bumiputera firm will be ...
2 weeks ago
Re business mostly on the next list, wait & see what Mbright prepare their next move
2 weeks ago
Buy in both mother and warrant if you think MBRIGHT will deliver excellent QR in this month end 😉
2 weeks ago
if trend reversal happening then good lor, been trading at 0.14-0.16 for some time alrdy
2 weeks ago
No worries, if you have holding powers and time, surely can wait for it to move higher
2 weeks ago
It's a good sign and I definitely can look forward Meta Bright to announce an impressive Q3 report
1 week ago
Invest in it instead of trading because your patience will be rewarded one day with this investment
1 week ago
I called it 😉
OptionOracle
Buy in both mother and warrant if you think MBRIGHT will deliver excellent QR in this month end 😉
1 week ago
1 week ago
Good news comes before the QR. Meta Bright has signed a memorandum of understanding (MOU) with ChemPartner Pharmatech Co Ltd to develop a pharmaceutical and biotechnology (biotech) hub in Malaysia.
https://theedgemalaysia.com/node/713115
5 days ago
Meta Bright said ChemPartner, a listed company on the Shenzhen Stock Exchange with a market capitalisation of approximately RM1.6 billion, is renowned for offering comprehensive, integrated services, including discovery chemistry, biology, pharmacology, drug metabolism and pharmacokinetics, and toxicology.
5 days ago
yupe, currently the company has hotel, energy efficiency, building materials, and the leasing business. After the establishment of MOA, pharmaceutical and biotechnology businesses will be included 🙂
4 days ago
Meta Bright managing director Lee Chee Kiang said this project would differentiate the company from typical developments, as it involves creating a niche market with a leader in the pharmaceutical and biotech sectors.
wonder what kind of niche market Metabright is aiming for
4 days ago
Revenue increase by alot, mainly the new building materials subsidiary, Expogaya contributed revenue of RM24.050 million.
3 days ago
overall result are better than expected, new subsidiary actually performing well...
3 days ago
Great, revenue hits historical high. But, PAT decreased due to higher finance cost and depreciation
3 days ago
Commendable QR and potentially expanding into pharmaceutical and biotechnology businesses. Better accumulate it while you have free cash
2 days ago
haha if someone push down then I collect hehehe, anyway congrats to the performancce
2 days ago
I had accumulated enough when it was at 15 cents and below there, hehe. Just waiting for it to move up to 20 cents and above
2 days ago
Mbright is exhibiting signs of concluding its consolidation phase, highlighted by a recent breakout from the RM0.160 level, which now serves as a key support level
1 day ago
just a matter of time for it to break through key resistance level of RM0.180 again
1 day ago
Thealanor
ok la, ez to get more contract from gov if got experience working with bumi companies
2 weeks ago